Sleep, Wake and Light therapy for depression

Similar documents
Adult Patient Information and Consent Form

South London and Maudsley. NHS Foundation Trust. Southwark Child and Adolescent Mental Health Service. Information for young people (12-18 years)

Couples Information Leaflet

Patient Information Sheet Opportunistic Detection of Atrial Fibrillation in Ambulatory Blood Pressure Monitoring

A study of Standard and New Antiepileptic Drugs SANAD-II

UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH PARTICIPANT INFORMATION SHEET

PATIENT INFORMATION SHEET (Sheffield and Southampton Only)

PATIENT STUDY INFORMATION LEAFLET

Patient information leaflet. A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD)

VANISH Vasopressin vs Noradrenaline as Initial therapy in Septic shock

A study about how parts of the brain work in people with Down syndrome

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1

PATIENT INFORMATION SHEET

Suspected CANcer (SCAN) Pathway Information for patients

The Psychiatric Liaison Team for Older Adults

Information Sheet for Stage 1 Screening for parents

BIOmarkers in DEPression (BIODEP) Information Sheet for Healthy Volunteers

Information about our service

GP Information Sheet

PATIENT STUDY INFORMATION LEAFLET

FLIPS FreeStyle Libre in Pregnancy Study

Barrett s Oesophagus

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Life After Prostate Cancer Diagnosis Research Study

Lambeth Early Onset (LEO) Team

Perinatal Community Service (Croydon)

Patient Information Sheet

Assessment and Liaison Outreach Team

Help is at hand. Lambeth. Problems at work? Depressed? Stressed? Phobias? Anxious? Can t find work? Lambeth Psychological Therapies

Smile. Your dental team have check ups too

What are the experiences of therapeutic relationships on in-patient wards by people who dissociate?

HREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.

SMOKING CESSATION STUDY SERVICE USER INFORMATION SHEET. Thank you! Information about our research and invitation to take part in our study

Lambeth Psychological Therapies

VACCINE REMINDER SERVICE A GUIDE FOR SURGERIES

risk Does my epilepsy put me at risk?

Older People s Community Mental Health Team

PARTICIPANT INFORMATION SHEET Version 2 09/ IRAS Ref No.:

MYSTERY SHOPPERS AT BHRUT. Welcome Presentation

Bristol Children s Vaccine Centre

COUPLE INFORMATION SHEET AND INFORMED CONSENT FORM

Genetic testing for breast cancer susceptibility

information for people who self-harm If you ve harmed yourself and you need IMMEDIATE and URGENT help:

Adult ADHD Service Patient Information Leaflet

PATIENT INFORMATION SHEET. BIOPROP20: Biologically optimised IMRT for Prostate Radiotherapy

Buprenorphine treatment

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

Electro-convulsive Therapy (ECT) Your questions answered

INFORMATION AND CONSENT FORM

Child and Adolescent Mental Health Service (CAMHS)

LOVEMEAD GROUP PRACTICE PATIENT PARTICIPATION GROUP YEAR END REPORT 2013/14. Introduction

We are doing some research. It is about practising standing up early. after stroke. Research helps us learn. We need to know more about how to

CAMHS. Your guide to Child and Adolescent Mental Health Services

Transition for Children and Young People (age 0-18 years) with Diabetes

About your fistula for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Having a kidney biopsy. Information for patients Sheffield Kidney Institute (Renal Unit)

A guide for MSPs/MPs and Parliamentary Staff

Red blood cell transfusion

The Bexley Memory Service

About this consent form

DEPRESSION. Teenage. Parent s Guide to

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

North Tyneside West Community Mental Health Team Patient Information Leaflet

information for people who self-harm If you ve harmed yourself and you need IMMEDIATE and URGENT help: Phone 999 and ask for an ambulance

WEB device for treating brain (intracranial) aneurysms

About your tunnelled dialysis catheter. Information for patients Sheffield Kidney Institute (Renal Unit)

Please do not hesitate to contact us (see below) if there is anything that is not clear or if you would like more information.

PReSUTINeB Study. Participant Information Sheet: Prevention of Recurrent Symptomatic Urinary Tract Infections in

CONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith

Sleep deprived video electroencephalogram (EEG)

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections Study INFORMATION SHEET FOR PATIENT 18th August Version 3.

The Touchstone Centre. South London and Maudsley. NHS Foundation Trust

Participant Information Sheet

About Your Ventricular Assist Device (VAD) Surgery

Perinatal Community Mental Health Team Patient Information Leaflet

A practical guide to living with and after cancer. Helping you take an active role in your cancer care

About your graft for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Duloxetine. For the Treatment of Pain

A practical guide to living with and after cancer. Planning your care and support. Front cover

NCI Community Oncology Research Program Kansas City (NCORP-KC)

Amitriptyline, Nortriptyline or Imipramine

PARTICIPANT INFORMATION SHEET: EBL04

Medication Information for Parents and Teachers

Information about Age UK Manchester s Information & Advice Service

Here4me Action for Children PROTOCOL FOR THE PROVISION OF ADVOCACY for West Berkshire

Direct access to intelligent care for healthier muscles, joints and bones. Working Body Member guide

Having a vitrectomy surgery to repair your retinal detachment

Vertebroplasty Balloon kyphoplasty What has NICE said? Who can have vertebroplasty and kyphoplasty? Why has NICE said this?

Watch and wait (active monitoring)

Having inhalation sedation for your dental treatment

South London and Maudsley NHS Foundation Trust. Lewisham Children and Young People s Service - CAMHS. Information for professionals.

Enhanced Recovery Programme Liver surgery

Be on the TEAM: Teenagers against Meningitis

Vanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age:

INFORMATION BROCHURE - ALLOCATE

Mid Essex Specialist Dementia and Frailty Service

A Guide for Homeless 16 & 17 year olds

Welcome to your Addiction Recovery Community Hub. Patient information leaflet ARCH North

Transcription:

Sleep, Wake and Light therapy for depression We would like to invite you to take part in a study called Sleep, Wake and Light Therapy for treating depression You do not have to take part if you do not want to. Please read this information leaflet to help you decide. INFORMATION SHEET Part 1 tells you the purpose of this study and what will be involved if you take part. Part 2 gives you more detailed information about the study. Please do not hesitate to ask us if there is anything that is not clear or if you would like more information. Contact details can be found at the end of the document. Take time to decide whether you wish to take part. Thank you for taking the time to read this information. Part 1 1. What is the purpose of the study? The aim of this study is to determine if altering the pattern of your sleep and having light therapy can speed up the treatment of your depression. 2. Why have I been chosen? You have been chosen because you are currently suffering from depression. 3. Do I have to take part? No, it is entirely up to you to decide whether to take part. If you do not want to take part that s OK. Your decision will not affect the quality of care you receive. We will 1

give you an opportunity to ask any questions you may have. We will then give you this information sheet to read in your own time. If you agree to take part, we will ask you to sign a consent form to show you have agreed to take part. However, even after giving consent to take part; you are free to withdraw at any time, without giving a reason, by contacting the researchers at the end of this information leaflet. 4. What will I need to do if I take part? If you decide to take part, you will be interviewed by a research worker who will ask about your condition and to complete various questionnaires. If you are taking medication for depression, this should be kept at the same dose. You and your doctor should not be planning to change the dose of your current medication or to start a new medication for depression in the next 4 weeks. You should continue to receive any talking therapy or other treatments for depression. If you choose to participate, you will be given a wristband to wear for 3 days before the new treatment begins and for 7 days after the treatment. During this time you will also be asked to rate your mood on a daily basis. You will be allocated by chance to one of the two new treatments described below. This is illustrated with the flowchart on the next page: 1) Sleep Therapy and a Light Box: You will be given information and advice on how to get a good night s sleep. You will be also given a light box to use in the morning for 1 week. For the light box, you will be asked to sit about one foot away from a light box. You will be free to have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes when you get up. You may continue to have any treatment as usual (for example medication or talking therapies). 2) Wake therapy and a Light Box: You will be helped to change the pattern of your sleep by depriving you of sleep for one night. On Day 1 (e.g. a Monday), you will be supported to stay up all night and the following day at the Hospital. We will arrange various activities to help you stay awake accompanied by a nursing assistant during the night and the following day. You can go to bed by 5pm at your home on Day 2 (e.g. Tuesday). You will need to get up by about 1am and return to the hospital to be supported to stay awake. You will then go to bed at 7pm on Day 3 (e.g. Wednesday). You will be asked to sleep until 3am and then stay awake at home until bed at 9pm on Day 4 (Thursday). You will then get up by 5am on Day 5 (Friday) and stay awake until 11pm to resume a normal sleep routine waking by 7am on Day 6 (Saturday). You will also be given a light box to use each morning. For the light box, you will be asked to sit about one foot away from a light box. You will be free to 2

have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes. You may continue to have treatment as usual (for example medication or talking therapies). You will be asked to complete various questionnaires and be interviewed at 1 week, 2 weeks, 4 weeks, 8 weeks and at 6 months after starting. You will be asked to make 6 extra visits to the research team at the hospital over and above those needed for your normal care. We can pay the public travel expenses for these visits. Alternatively, the interview can be completed over the telephone and the questionnaires can be completed over the internet. FLOWCHART You will be given a wristband to wear for 3 days before the treatment begins and for 7 days after the treatment begins You will then be allocated by chance to one of two treatments Group 1: Sleep and Light Therapy for 7 days Group 2: Wake and Light Therapy for 7 days Follow up with measures at 1 week, 2 weeks, 4 weeks, 8 weeks and at 6 months 3

5. What are the side effects of taking part? Possible side effects include tiredness after altering your pattern of sleep. A few people may experience nausea or headache after beginning light therapy. In this case, the time in front of the light may decrease by 10 minutes. The frequency of any side effects from the treatment will be monitored and your doctor or therapists would continue with treatment as usual. 6. What are the possible disadvantages or risks of taking part? One of the possible disadvantages may be the time and burden to complete the questionnaires and attend the research interview. The only potential risk of treatment is of triggering an episode of mania, but this should be a rare occurrence as we are excluding from this study people with bipolar disorder. 7. What are the possible benefits of taking part? We cannot promise this treatment will help you, but it may help some people with depression. Information we get from this study will help us better understand whether it can be a practical treatment in the community and whether it is worth doing a larger study. 8. What if there is a problem? Any complaint about the way you have been dealt with during the study or any possible harm you might suffer will be addressed. The detailed information on this is given in Part 2. 9. What happens when the research study stops? A summary of the results of this research will be made available to all those taking part who would like to receive this. You will be provided with a summary of the main research findings. Your anonymized data will be kept for a maximum of 10 years while publication and further research procedures might take place. 10. Will my taking part in this study be kept confidential? Yes. Your medical information will be kept strictly confidential. We will follow ethical and legal practice and all information about you will be handled in confidence. The researchers may need to check information in your medical notes. If the information in Part 1 has interested you and you are considering participation, please read the additional information in Part 2 before making any decision. 4

PART 2 1. What will happen if I don t want to carry on with the study? You can withdraw from the study at any time without giving a reason and without your current care being affected. Any identifiable data collected will be destroyed. Data that is not identifiable may still be used. If you do not wish to take part in the research study then you may still carry on with the routine care. 2. What happens if something goes wrong? If you have a concern about any aspect of this study, you should ask to speak to Professor David Veale who will do his best to answer your questions (see contact details below). If you remain unsatisfied and wish to complain formally, you can do this through the NHS Complaints mechanism. You can obtain advice and information on making a complaint from the Patient Advice and Liaison Service (PALS). You can contact the Maudsley PALS on Freephone 0800 731 2864 or by email at pals@slam.nhs.uk. In the event, that something does go wrong and you are harmed during the research and this is due to someone s negligence, then you may have grounds for a legal action for compensation, but you may have to pay your legal costs. 3. What will happen to the results of the research study? Findings from the research will be published in scientific journals and publicised in the media. You will be sent a summary of the results and may request a copy of the paper. You will not be identified in any report or publication arising from the research. 4. Will my taking part in this study be kept confidential? All information about you, which is collected during the research, will be kept confidential. All data will be anonymous. You will be assigned a participation code at the beginning of the study and the list linking the names of participants to their code will be kept separate from the data, in a locked filing cabinet. Only staff working on the project will have access to the data you provide. Electronic copies of data are stored on computers with username and password security required to gain access. No electronic copies of data will be transferred to portable data devices. Hard paper copies of any information you share with us will be kept in folders in a locked filing cabinet. No personally identifiable information is at any time being transferred outside of the hospital. Both computers and filing cabinets are stored in the clinic building at the Maudsley Hospital, which is locked with a security code and alarm system. You may be asked if you would like your GP to be informed of your participation in the research. This is because it can be useful for your medical records to note any form of treatment you have received. However, this decision will be yours, and if you do decide that it is OK for us to inform your GP, this information will remain confidential in line with patient information legislation. You are also being asked to 5

consent to your data (for example the outcome of the rating scales) being shared anonymously with other researchers, for example if they request to check on our analysis. 5. Who has reviewed the study? All research in the NHS is looked at by an independent group of people, called a Research Ethics Committee, to protect your interests. This study has been reviewed and been given favorable opinion by London - Bromley Research Ethics Committee (Reference 17/LO/1567). 6. What will happen if those running the study become concerned for my safety? If those conducting the research become concerned for your safety (for example a risk of suicide) they will be bound by a duty of care and limitations to confidentiality to report any concerns to a third-party professional. As examples, a third party may refer to a GP or a staff member at accident and emergency. Contact for Further Information For further information, please do not hesitate to discuss the study with the research worker who has assessed you or the Chief Investigator, Professor David Veale. Dr Clara Humpston, Research Associate By email: Clara.Humpston@kcl.ac.uk By telephone: 07553 518853 By email: David.Veale@kcl.ac.uk By post: Professor David Veale Centre for Anxiety Disorders and Trauma The Maudsley Hospital 99 Denmark Hill London SE5 8AZ By telephone: 020 3228 3461 You will be given a copy of the information sheet and a signed consent form to keep. Thank you for considering taking part in the study. 6